Business Description
Assembly Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US0453961080
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 62.55 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -9.44 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -61.2 | |||||
3-Year EBITDA Growth Rate | 13.6 | |||||
3-Year EPS without NRI Growth Rate | 14 | |||||
3-Year Book Growth Rate | -55.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 75.84 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.91 | |||||
9-Day RSI | 33.19 | |||||
14-Day RSI | 39 | |||||
6-1 Month Momentum % | 16.35 | |||||
12-1 Month Momentum % | 57.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.74 | |||||
Cash Ratio | 2.65 | |||||
Days Sales Outstanding | 4.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.6 | |||||
Shareholder Yield % | -21.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -235.24 | |||||
Net Margin % | -212.33 | |||||
FCF Margin % | 109.75 | |||||
ROE % | -111.22 | |||||
ROA % | -46.52 | |||||
ROIC % | -191.35 | |||||
3-Year ROIIC % | -0.34 | |||||
ROC (Joel Greenblatt) % | -2344.61 | |||||
ROCE % | -71.17 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 4.53 | |||||
PS Ratio | 3.81 | |||||
PB Ratio | 2.73 | |||||
Price-to-Tangible-Book | 2.73 | |||||
Price-to-Free-Cash-Flow | 3.47 | |||||
Price-to-Operating-Cash-Flow | 3.47 | |||||
EV-to-EBIT | 0.26 | |||||
EV-to-EBITDA | 0.26 | |||||
EV-to-Revenue | -0.6 | |||||
EV-to-Forward-Revenue | 0.35 | |||||
EV-to-FCF | -0.53 | |||||
Price-to-Net-Current-Asset-Value | 2.93 | |||||
Price-to-Net-Cash | 3.31 | |||||
Earnings Yield (Greenblatt) % | 384.62 | |||||
FCF Yield % | 25.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Assembly Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 19.817 | ||
EPS (TTM) (€) | -7.998 | ||
Beta | 1.08 | ||
Volatility % | 37.85 | ||
14-Day RSI | 39 | ||
14-Day ATR (€) | 0.722545 | ||
20-Day SMA (€) | 14.895 | ||
12-1 Month Momentum % | 57.95 | ||
52-Week Range (€) | 7.092 - 19.128 | ||
Shares Outstanding (Mil) | 6.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Assembly Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Assembly Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Assembly Biosciences Inc Frequently Asked Questions
What is Assembly Biosciences Inc(FRA:V7B)'s stock price today?
When is next earnings date of Assembly Biosciences Inc(FRA:V7B)?
Does Assembly Biosciences Inc(FRA:V7B) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |